MedTrace Logo

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

NCT05763199 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-03-12

No results posted yet for this study

Summary

This is a pilot phase, randomized, double-blinded feasibility pilot study of AHCC in participants with ovarian cancer.

Conditions

  • Ovarian Epithelial Carcinoma
  • Fallopian Tube Carcinoma
  • Peritoneal Carcinoma

Interventions

DIETARY_SUPPLEMENT

AHCC

AHCC is the cultured mycelia of Lentinula edodes mushrooms from the Basidiomycetes family.

DRUG

Chemotherapy

Chemotherapy will be administered per standard of care.

OTHER

Placebo

Dextrin

Sponsors & Collaborators

  • Amino Up Chemicals Co., Ltd.

    collaborator INDUSTRY

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Hui Chen, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2026-12-31
Completion
2027-03-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763199 on ClinicalTrials.gov